Bank Pictet & Cie (Europe)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Hold
16,280
0.06% 98
2026
Q1
$2.75M Hold
16,280
0.06% 104
2025
Q4
$2.75M Hold
16,280
0.05% 99
2025
Q3
$2.35M Hold
16,280
0.05% 98
2025
Q2
$2.06M Hold
16,280
0.04% 96
2025
Q1
$2.08M Sell
16,280
-1,000
-6% -$136K 0.05% 91
2024
Q4
$2.28M Buy
17,280
+1,000
+6% +$141K 0.05% 86
2024
Q3
$2.37M Hold
16,280
0.06% 85
2024
Q2
$2.23M Hold
16,280
0.05% 87
2024
Q1
$2.23M Buy
+16,280
New +$2.22M 0.06% 91
2017
Q4
Sell
-3,402
Closed -$378K 165
2017
Q3
$378K Sell
3,402
-1,863
-35% -$199K 0.05% 148
2017
Q2
$544K Sell
5,265
-4,797
-48% -$472K 0.08% 140
2017
Q1
$984K Sell
10,062
-1,110
-10% -$106K 0.14% 84
2016
Q4
$988K Buy
11,172
+474
+4% +$43.1K 0.17% 77
2016
Q3
$1.03M Sell
10,698
-2,349
-18% -$223K 0.19% 72
2016
Q2
$1.12M Buy
13,047
+2,865
+28% +$257K 0.23% 64
2016
Q1
$885K Hold
10,182
0.18% 69
2015
Q4
$1.15M Buy
+10,182
New +$1.11M 0.23% 65
2014
Q3
Sell
-2,460
Closed -$211K 151
2014
Q2
$211K Buy
+2,460
New +$194K 0.07% 126

Other funds holding IBB

Bank Pictet & Cie (Europe)'s IBB Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 16,280 shares worth $3.1M. The position accounts for 0.06% of the portfolio, ranked #98.

Bank Pictet & Cie (Europe) first reported a position in IBB in Q2 2014 and has held it in 19 quarters since. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 16,280 shares of iShares Biotechnology ETF worth $3.1M as of Q2 2026.
  • Bank Pictet & Cie (Europe) left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.06% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #98 holding.
  • Bank Pictet & Cie (Europe) first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 19 quarters since.
  • 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.